- The company has won Bionow Investment Deal of Year and Bionow Company of the Year
- Yourgene was awarded it for its acquisition of Elucigene, a Manchester-based molecular diagnostics manufacturer and developer
- The target was valued at an enterprise value of £8.8 million
- The company was also acknowledged by winning Bionow Company of the Year Award, sponsored by AstraZeneca
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.